Cathy N Lam

Array ( [id] => 8612749 [patent_doc_number] => 20130018061 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-01-17 [patent_title] => 'Method for Improving Exercise and Recovery From Exercise' [patent_app_type] => utility [patent_app_number] => 13/180872 [patent_app_country] => US [patent_app_date] => 2011-07-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2914 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13180872 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10864040 [patent_doc_number] => 08889739 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-11-18 [patent_title] => 'Use of trans-palmitoleate in identifying and treating metabolic disease' [patent_app_type] => utility [patent_app_number] => 13/809181 [patent_app_country] => US [patent_app_date] => 2011-07-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 13636 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13809181 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7720870 [patent_doc_number] => 20120010205 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-01-12 [patent_title] => 'NOVEL QUINOLINE ESTERS USEFUL FOR TREATING SKIN DISORDERS' [patent_app_type] => utility [patent_app_number] => 13/177908 [patent_app_country] => US [patent_app_date] => 2011-07-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13359 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0010/20120010205.pdf [firstpage_image] =>[orig_patent_app_number] => 13177908 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9589600 [patent_doc_number] => 08779140 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-07-15 [patent_title] => 'Crystal of fused pyridine compound salt' [patent_app_type] => utility [patent_app_number] => 13/806909 [patent_app_country] => US [patent_app_date] => 2011-06-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 9763 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13806909 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9575382 [patent_doc_number] => 08765797 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-07-01 [patent_title] => 'TG2 inhibitors and uses thereof' [patent_app_type] => utility [patent_app_number] => 13/806257 [patent_app_country] => US [patent_app_date] => 2011-06-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 45 [patent_figures_cnt] => 85 [patent_no_of_words] => 17085 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13806257 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7670177 [patent_doc_number] => 20110319446 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-29 [patent_title] => 'BICYCLO[2.2.1]HEPT-7-YLAMINE DERIVATIVES AND THEIR USES' [patent_app_type] => utility [patent_app_number] => 13/164209 [patent_app_country] => US [patent_app_date] => 2011-06-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 25773 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13164209 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7733742 [patent_doc_number] => 20120016026 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-01-19 [patent_title] => 'Compositions containing non-polar compounds' [patent_app_type] => utility [patent_app_number] => 13/134927 [patent_app_country] => US [patent_app_date] => 2011-06-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 96059 [patent_no_of_claims] => 52 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0016/20120016026.pdf [firstpage_image] =>[orig_patent_app_number] => 13134927 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9122209 [patent_doc_number] => 20130289131 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-10-31 [patent_title] => 'INJECTABLE PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF JOINTS' [patent_app_type] => utility [patent_app_number] => 13/807545 [patent_app_country] => US [patent_app_date] => 2011-06-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4671 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13807545 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8792723 [patent_doc_number] => 20130109692 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-05-02 [patent_title] => 'SIGMA LIGANDS FOR THE PREVENTION AND/OR TREATMENT OF EMESIS INDUCED BY CHEMOTHERAPY OR RADIOTHERAPY' [patent_app_type] => utility [patent_app_number] => 13/698718 [patent_app_country] => US [patent_app_date] => 2011-05-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 13929 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13698718 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8976135 [patent_doc_number] => 20130209565 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-08-15 [patent_title] => 'POSOLOGY AND ADMINISTRATION OF GLUCOCORTICOID BASED COMPOSITIONS' [patent_app_type] => utility [patent_app_number] => 13/696894 [patent_app_country] => US [patent_app_date] => 2011-05-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 16600 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13696894 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11210858 [patent_doc_number] => 09439875 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-09-13 [patent_title] => 'Anxiolytic effect of pterostilbene' [patent_app_type] => utility [patent_app_number] => 13/105470 [patent_app_country] => US [patent_app_date] => 2011-05-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 7794 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 74 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13105470 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8815287 [patent_doc_number] => 20130116333 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-05-09 [patent_title] => 'SOLID TAPENTADOL IN NON-CRYSTALLINE FORM' [patent_app_type] => utility [patent_app_number] => 13/695433 [patent_app_country] => US [patent_app_date] => 2011-05-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 11834 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13695433 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6048582 [patent_doc_number] => 20110207712 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-08-25 [patent_title] => 'Phosphatidylinositol 3-Kinase Inhibitors And Methods Of Their Use' [patent_app_type] => utility [patent_app_number] => 13/096942 [patent_app_country] => US [patent_app_date] => 2011-04-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 70423 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0207/20110207712.pdf [firstpage_image] =>[orig_patent_app_number] => 13096942 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7487928 [patent_doc_number] => 20110251253 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-13 [patent_title] => 'SOLID FORMS OF (R)-1-(2,2-DIFLUOROBENZO[D][1,3]DIOXOL-5-YL)-N-(1-(2,3-DIHYDROXYPROPYL)-6-FLUORO-2-(1-HYDROXY-2-METHYLPROPAN-2-YL)-1H-INDOL-5-YL) CYCLOPROPANECARBOXAMIDE' [patent_app_type] => utility [patent_app_number] => 13/072380 [patent_app_country] => US [patent_app_date] => 2011-03-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 26027 [patent_no_of_claims] => 79 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0251/20110251253.pdf [firstpage_image] =>[orig_patent_app_number] => 13072380 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8664467 [patent_doc_number] => 08377929 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-02-19 [patent_title] => 'Crystalline forms of the tri-mesylate salt of perphenazine-GABA and process of producing the same' [patent_app_type] => utility [patent_app_number] => 13/034453 [patent_app_country] => US [patent_app_date] => 2011-02-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 16 [patent_no_of_words] => 16344 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13034453 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9345236 [patent_doc_number] => 08664384 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-03-04 [patent_title] => 'N6-(ferrocenmethyl)quinazolin-2,4,6-triamina (H2) and the derivatives and prodrugs thereof as antileishmanial, antiprotozoal, antiparasitic and antimicrobial agents' [patent_app_type] => utility [patent_app_number] => 13/643949 [patent_app_country] => US [patent_app_date] => 2011-02-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 2366 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13643949 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6064234 [patent_doc_number] => 20110201588 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-08-18 [patent_title] => 'Post Foaming Gel Composition Comprising An Anti-Irritation Agent' [patent_app_type] => utility [patent_app_number] => 13/028865 [patent_app_country] => US [patent_app_date] => 2011-02-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5716 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0201/20110201588.pdf [firstpage_image] =>[orig_patent_app_number] => 13028865 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6000554 [patent_doc_number] => 20110117027 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-19 [patent_title] => 'INJECTABLE VOID FILLER FOR SOFT TISSUE AUGMENTATION' [patent_app_type] => utility [patent_app_number] => 13/004179 [patent_app_country] => US [patent_app_date] => 2011-01-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 5251 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0117/20110117027.pdf [firstpage_image] =>[orig_patent_app_number] => 13004179 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8483815 [patent_doc_number] => 20120283223 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-11-08 [patent_title] => 'CEREBRAL NERVE CELL NEOGENESIS AGENT' [patent_app_type] => utility [patent_app_number] => 13/520899 [patent_app_country] => US [patent_app_date] => 2011-01-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 7614 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13520899 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5986748 [patent_doc_number] => 20110098250 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-04-28 [patent_title] => 'WATER-SOLUBLE BENZOAZEPINE COMPOUND AND ITS PHARMACEUTICAL COMPOSITION' [patent_app_type] => utility [patent_app_number] => 12/980266 [patent_app_country] => US [patent_app_date] => 2010-12-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 13225 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0098/20110098250.pdf [firstpage_image] =>[orig_patent_app_number] => 12980266 [rel_patent_id] =>[rel_patent_doc_number] =>)